We are live on ! Find out more
WA

Wasatch Advisors Portfolio holdings

AUM $15.3B
1-Year Est. Return 25.06%
This Fund
S&P 500
This Quarter Est. Return
-9.54%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$17.9B
AUM Growth
-$2.28B
Cap. Flow
+$102M
Cap. Flow %
0.57%
Top 10 Hldgs %
24.95%
Holding
252
New
20
Increased
111
Reduced
97
Closed
18

Top Buys

Rank Stock Value
1
NPO icon
Enpro
NPO
+$143M
2
CAMT icon
Camtek
CAMT
+$142M
3
FRPT icon
Freshpet
FRPT
+$95.1M
4
UFPI icon
UFP Industries
UFPI
+$90M
5
NU icon
Nu Holdings
NU
+$70M

Sector Composition

Rank Sector Weight
1 Technology 24.98%
2 Industrials 19.01%
3 Financials 14.74%
4 Consumer Discretionary 14.63%
5 Healthcare 12.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASUR icon
176
Asure Software
ASUR
$242M
$6.15M 0.03%
+643,575
New +$7.05M
LFVN icon
177
LifeVantage
LFVN
$80.1M
$6.1M 0.03%
+418,576
New +$7.9M
DGII icon
178
Digi International
DGII
$2.47B
$6.05M 0.03%
217,336
-38,387
-15% -$1.18M
SHOE
179
Shoe Station Group
SHOE
$424M
$5.85M 0.03%
265,821
-41,426
-13% -$1.05M
CWCO icon
180
Consolidated Water Co
CWCO
$472M
$5.72M 0.03%
233,486
+61,870
+36% +$1.65M
DUK icon
181
Duke Energy
DUK
$101B
$5.52M 0.03%
45,276
-7,900
-15% -$901K
DERM icon
182
Journey Medical
DERM
$169M
$5.49M 0.03%
+930,603
New +$4.58M
EXC icon
183
Exelon
EXC
$48.1B
$5.41M 0.03%
117,327
-15,281
-12% -$639K
DYN icon
184
Dyne Therapeutics
DYN
$4.15B
$5.35M 0.03%
511,048
+190,422
+59% +$2.72M
ROP icon
185
Roper Technologies
ROP
$40.4B
$5.07M 0.03%
8,594
+1,020
+13% +$572K
MYFW icon
186
First Western Financial
MYFW
$306M
$4.93M 0.03%
250,684
-79,133
-24% -$1.55M
NATR icon
187
Nature's Sunshine
NATR
$362M
$4.88M 0.03%
388,498
-90,777
-19% -$1.28M
JPM icon
188
JPMorgan Chase
JPM
$916B
$4.83M 0.03%
19,684
+500
+3% +$127K
CMRC
189
Commerce.com Inc Series 1
CMRC
$272M
$4.7M 0.03%
815,171
-1,258,503
-61% -$8M
SGMO
190
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.5M 0.03%
6,868,766
-2,362,739
-26% -$2.5M
UNP icon
191
Union Pacific
UNP
$174B
$4.48M 0.03%
18,965
+43
+0.2% +$10.4K
VICI icon
192
VICI Properties
VICI
$29.9B
$4.4M 0.02%
134,870
+2,050
+2% +$63.2K
EVRG icon
193
Evergy
EVRG
$19.4B
$4.36M 0.02%
63,230
MGNX icon
194
MacroGenics
MGNX
$233M
$4.13M 0.02%
3,250,248
-238,245
-7% -$622K
VZ icon
195
Verizon
VZ
$197B
$4.07M 0.02%
89,734
-7,900
-8% -$329K
CVX icon
196
Chevron
CVX
$382B
$4.05M 0.02%
24,211
+2,700
+13% +$423K
T icon
197
AT&T
T
$164B
$3.89M 0.02%
137,719
-27,281
-17% -$686K
STRL icon
198
Sterling Infrastructure
STRL
$15.2B
$3.87M 0.02%
34,183
-13,734
-29% -$1.93M
DOX icon
199
Amdocs
DOX
$6.03B
$3.83M 0.02%
41,900
+1,040
+3% +$90.8K
NKTX icon
200
Nkarta
NKTX
$152M
$3.8M 0.02%
2,066,010
-454,899
-18% -$933K

Similar funds

Wasatch Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Wasatch Advisors held 252 positions worth $17.9B, down 11% from $20.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wasatch Advisors's Q1 2025 filing shows 20 new, 111 increased, 97 reduced and 18 closed positions. Its largest new stake was Enpro: 794,882 shares worth $129M. The largest sale was Intra-Cellular Therapies Inc., an estimated $271M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Industrials and Financials.

  • Wasatch Advisors's largest Q1 2025 buy was Enpro: 794,882 shares worth $129M.
  • Wasatch Advisors added most to Camtek in Q1 2025, an estimated $142M increase.
  • Wasatch Advisors's biggest Q1 2025 reduction was Dutch Bros, cutting an estimated $184M.
  • Wasatch Advisors fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $271M.
  • Wasatch Advisors's ten largest holdings make up 25% of its $17.9B portfolio in Q1 2025.
  • Wasatch Advisors opened 20 new positions and closed 18 in Q1 2025.
  • Wasatch Advisors's portfolio value fell 11% quarter-over-quarter to $17.9B.

Based on Wasatch Advisors's 13F filing for Q1 2025, filed 15 May 2025.